Equine or porcine synovial fluid as a novel ex vivo model for the study of bacterial free-floating biofilms that form in human joint infections.
Authors: Gilbertie Jessica M, Schnabel Lauren V, Hickok Noreen J, Jacob Megan E, Conlon Brian P, Shapiro Irving M, Parvizi Javad, Schaer Thomas P
Journal: PloS one
Summary
# Editorial Summary Septic arthritis and periprosthetic joint infections present significant clinical challenges in both human and veterinary orthopaedics, largely because bacteria within infected joints form free-floating biofilm aggregates that confer marked resistance to systemic antibiotic therapy. Gilbertie and colleagues developed an innovative ex vivo model using fresh equine and porcine synovial fluid to study how *Staphylococcus aureus* and other pathogenic bacteria establish these biofilm phenotypes, circumventing previous limitations of small animal models that produce insufficient synovial fluid for meaningful in vitro investigation. Their findings demonstrated that bacterial pathogens adopt identical biofilm aggregate structures and antimicrobial tolerance profiles in both large animal synovial fluids as have been documented in human clinical specimens—a crucial validation bridging the translational gap. Importantly, enzymatic dispersal of these synovial fluid–induced aggregates restored antimicrobial efficacy, suggesting a mechanistic target for therapeutic intervention. For equine and small ruminant practitioners managing septic joints, these results support the biological reality that biofilm-mediated antimicrobial tolerance is fundamental to treatment failure in naturally occurring infections, whilst the model itself offers farriers, veterinarians, and researchers a practical platform to investigate host–pathogen interactions and screen novel intervention strategies without relying on in vivo animal studies.
Read the full abstract on PubMed
Practical Takeaways
- •Equine and porcine synovial fluid models provide a practical alternative to rodent models for studying joint infections and biofilm formation, with abundant fluid samples available for research
- •Bacterial biofilms in infected joints explain clinical resistance to standard antibiotic therapy—treatment may require adjunctive strategies to disrupt biofilm architecture alongside antimicrobials
- •Future therapeutic approaches targeting biofilm disruption mechanisms could improve outcomes in difficult-to-treat joint infections in both horses and humans
Key Findings
- •Staphylococcus aureus and other bacterial pathogens form biofilm aggregates with antimicrobial tolerance in both equine and porcine synovial fluid, comparable to human synovial fluid
- •Bacteria within synovial fluid biofilms demonstrate significantly increased antimicrobial tolerance even at high antibiotic concentrations
- •Enzymatic dispersal of synovial fluid biofilm aggregates restores antimicrobial efficacy